Oxaprozin: a once-daily treatment regimen in rheumatoid arthritis
Reynolds, W.J.; Shaar, S.F.; Buik, A.; Lancee, W.J.
Journal of Rheumatology 6(3): 345-350
1979
ISSN/ISBN: 0315-162X PMID: 385873 Document Number: 4409
The development of oxaprozin provided an opportunity to evaluate the control of inflammation in rheumatoid arthritis by a drug that can be administered once daily. A double-blind 12-week evaluation suggested comparable efficacy between 1,200 mg oxaprozin given as a single daily dose and 3,900 mg ASA given in 4 equally divided doses. A lower incidence of side effects was noted in the oxaprozin group. An open 6-month study substantiated the efficacy and safety of oxaprozin.
Document emailed within 1 workday
Related Documents
O'Connor, T.P.; Anderson, A.M.; Lennox, B.; Muldoon, C. 1993: A novel sustained-release formulation of ibuprofen provides effective once-daily therapy in the treatment of rheumatoid arthritis and osteoarthritis British Journal of Clinical Practice 47(1): 10-13Miller, L.G. 1992: Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug Clinical Pharmacy 11(7): 591-603
Carter, H.; Chevallier, J.; Ghoussoub, K.; Paolaggi, J.B. 1986: Surveys conducted by the epidemiology team of the french rheumatology society concerning the prescription of d penicillamine in the treatment of rheumatoid arthritis i. survey of the opinions of rheumatologists concerning the prescription regimen Revue du Rhumatisme et des Maladies Osteo-Articulaires 53(5): 331-334
Mowat, A.M.; Mowat, A.G.; Jones, C.W.; Engler, C. 1984: A comparison of once and twice daily naproxen in rheumatoid arthritis British Journal of Clinical Practice 38(3): 95-98
Suzuki, K.; Takeuchi, T. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis Clinical Calcium 28(5): 626-629
Yamanaka, H. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. how to use the guideline in the management of rheumatoid arthritis Clinical Calcium 28(5): 607-610
Mainardi, C.L.; Walter, J.M.; Spiegel, P.K.; Goldkamp, O.G.; Harris, E.D. 1979: Rheumatoid arthritis: failure of daily heat therapy to affect its progression Archives of Physical Medicine and Rehabilitation 60(9): 390-393
Soubrier, M.; Zerkak, D.; Gossec, L.; Ayral, X.; Roux, C.; Dougados, M. 2006: Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice? Journal of Rheumatology 33(7): 1243-1246
Heitmann, B.L.; Kondrup, J.; Engelhart, M.; Kristensen, J.H.; Pødenphant, J.; Høie, H.; Andersen, V. 1994: Changes in fat free mass in overweight patients with rheumatoid arthritis on a weight reducing regimen. A comparison of eight different body composition methods International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 18(12): 812-819
Yasuda, S. 2018: Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Best practice in the use of T cell co-stimulatory inhibitor for patients with rheumatoid arthritis Clinical Calcium 28(5): 668-676
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Bradsher, R.W.; Snow, R.M. 1984: Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen American Journal of Medicine 77(4c): 63-67
Nishikiori, H.; Nemoto, T.; Goto, S. 1972: Nursing approach in the care of ambulatory patients with chronic rheumatoid arthritis with special reference to their activities of daily living Nursing Technique 18(11): 76-80
Rademaker, M.; Corrie, J.; Lindsay, B.A.; Flapan, A.D.; Padfield, P.L. 1989: Low dose, twice daily captopril and frusemide: a safe, effective and flexible third line treatment regimen for hypertension Journal of Human Hypertension 3(3): 173-177
Revaz, S.; Dudler, J. 2008: Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis Revue Medicale Suisse 4(149): 712; 714 716-717
Langdon, C.G.; Moran, D.G.; Jamieson, V.; Spence, S.; Hill, S.A. 1990: A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice Journal of International Medical Research 18(6): 489-496
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Henrard, J.C.; Bennett, P.H.; Burch, T.A. 1974: Epidemiology of rheumatoid arthritis. Evaluation of the so-called Rome and new York criteria for the diagnosis of rheumatoid arthritis in a population study Revue du Rhumatisme et des Maladies Osteo-Articulaires 41(11): 675-683
Barrera, P.; Balsa, A.; Alves, H.; Westhovens, R.; Maenaut, K.; Cornélis, F.; Fritz, P.; Bardin, T.; Ceu Maia, M.; Lopes-Vaz, A.; Pascual Salcedo, D.; de la Concha, E.; Radstake, T.; van de Putte, L.B.; Migliorini, P.; Prudhomme, J.F.; Charron, D.; Spyropoulou, M.; Mendes, A.; Spaepen, M.; Martinez, M.; Stavropoulos, C. 2001: Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on Rheumatoid Arthritis Families (ECRAF) Journal of Rheumatology 28(5): 968-974
Jaller Char, J.J.; Jaller, J.A.; Waibel, J.S.; Bhanusali, D.G.; Bhanusali, N. 2018: The Role of IL-17 in the Human Immune System and its Blockage as a Treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 17(5): 539-542